Program: Education Program
Session: A Shifting Landscape: Treatment of MCL
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Real-world evidence
Session: A Shifting Landscape: Treatment of MCL
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Real-world evidence
Monday, December 9, 2024, 10:30 AM-11:45 AM
Disclosures: Palomba: Novartis: Consultancy; Synthekine: Consultancy; Cellectar: Consultancy; Bristo Meyer Squibb: Consultancy.
OffLabel Disclosure:
<< Previous Presentation
|
Next Presentation